Search Results 1-10 of 16302 for Imiglucerase
Description. Imiglucerase injection is used to treat type 1 Gaucher disease which may cause anemia (low number of red blood cells), thrombocytopenia (low ...
If you are also using imiglucerase, velaglucerase alfa, or taliglucerase alfa, take eliglustat 24 hours after taking the last dose of these medicines. Avoid ...
Taliglucerase alfa injection is used for the long-term treatment of type 1 Gaucher disease. This disease is caused by the lack of a certain enzyme in the body ...
Description. Alglucosidase alfa injection is an enzyme used to treat Pompe disease (glycogen storage disease type II), including infantile-onset Pompe ...
Description. Miglustat is used to treat mild to moderate type 1 Gaucher disease in people who cannot be treated with an enzyme replacement therapy.
Glucarpidase injection is used to treat too much methotrexate concentration in the blood in patients with severe kidney disease. This medicine is to be given ...
Imiglucerase (intravenous route) · Imipenem and cilastatin (intravenous route, intramuscular route) · Imipenem, cilastatin, and relebactam (intravenous route).
Glasdegib is used together with low-dose cytarabine to treat newly-diagnosed acute myeloid leukemia (AML) in adults 75 years of age and older or who have other ...
Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...
Voretigene neparvovec-rzyl injection is used to treat retinal dystrophy (a rare form of inherited loss of vision) with confirmed biallelic RPE65 mutation. This ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift today can have 5X the impact on AI research and technology. But hurry — the match challenge ends 9/19.